Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T20:26:45.069Z.
Calculation as of: 2026-10-06T20:26:45.069Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 33649c4c01683a9af2a16592a0768676bab1dc5ff5bd6572e384150bc13b4d03
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$231.77M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$231.37M
Free Cash Flow Yield
N/A
TTM Avg
1.01%
3Y Avg
1.01%
5Y Avg
1.01%
Market Cap
$235.08M
Free Cash Flow Yield
4.87%
TTM Avg
6.50%
3Y Avg
7.35%
5Y Avg
6.89%
Market Cap
$235.66M
Free Cash Flow Yield
17.05%
TTM Avg
15.02%
3Y Avg
15.02%
5Y Avg
15.02%
Market Cap
$235.97M
Free Cash Flow Yield
N/A
TTM Avg
17.89%
3Y Avg
12.79%
5Y Avg
11.00%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $232.72M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | N/A | 1.01% | 1.01% | 1.01% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 4.87% | 6.50% | 7.35% | 6.89% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 17.05% | 15.02% | 15.02% | 15.02% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | N/A | 17.89% | 12.79% | 11.00% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | N/A | N/A | N/A | N/A |
| Vogenx Inc. (VOGX)vs › | $227.91M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $227.60M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
